This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
2024 Drugs Pharmacy 
Drugs.com
OCTOBER 3, 2024
3, 2024 -- Americans who turn to online pharmacies to find cheaper versions of expensive prescription medications, especially opioids, may instead be buying themselves dangerous drugs that could trigger an overdose, U.S. THURSDAY, Oct.
Drugs.com
DECEMBER 4, 2024
4, 2024 -- About a third of America’s pharmacies have closed since 2010, amounting to an “unprecedented decline” in neighborhood drug stores, a new study finds.The drop began in 2018, primarily driven by store closures among chain ph. WEDNESDAY, Dec.
246
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drugs.com
APRIL 15, 2024
MONDAY, April 15, 2024 -- Americans are facing more shortages of the drugs they need for medical care than ever before, a national pharmacy database shows.The American Society of Health-System Pharmacists (ASHSP) and the University of Utah Drug.
278 
Drugs.com
JUNE 18, 2024
TUESDAY, June 18, 2024 -- Patients are less likely to fill prescriptions for the overdose-reversing drug naloxone when they have to shell out more at the pharmacy, a new study finds.Naloxone (also known by the brand name Narcan) is a critical.
289 
Drugs.com
SEPTEMBER 20, 2024
20, 2024 -- The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug Administration on Friday approved FluMist nasal spray as the first influenza vaccine that can be. FRIDAY, Sept.
290 
Drugs.com
SEPTEMBER 20, 2024
20, 2024 -- The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug Administration on Friday approved FluMist nasal spray as the first influenza vaccine that can be. FRIDAY, Sept.
279 
Drug Channels
MARCH 19, 2024
I am pleased to announce our new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. The 2024 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. Please contact us if you did not receive your email. All rights reserved.
96 
Drugs.com
OCTOBER 15, 2024
15, 2024 -- Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage. TUESDAY, Oct.
Drugs.com
FEBRUARY 27, 2024
2, 2024 -- For nearly a week, prescription drug orders have been disrupted at thousands of pharmacies as the largest health insurer in the United States tries to fully restore services following a cyberattack. TUESDAY, Feb. The security breach was.
264 
Drug Channels
NOVEMBER 15, 2023
In Medicare Part D in 2024: The Seven Largest Companies' Preferred Pharmacy Networks and the Coming Collapse of the PDP Market , I documented how those networks now dominate stand-alone Medicare Part D prescription drug plans (PDPs) and have become a major presence in Medicare Advantage prescription drug (MA-PD) plans.
98 
Drug Patent Watch
DECEMBER 10, 2024
India has long been recognized as a significant player in the global pharmaceutical industry, particularly in the production of generic drugs. This article delves into India’s growing importance in generic drug API manufacturing, highlighting the key factors contributing to its success and the challenges it faces. Califf, M.D.,
97 
Drug Channels
MARCH 7, 2024
On March 19, 2024, Drug Channels Institute will release The 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. drug pricing, reimbursement, and dispensing system. prescription drug channels. prescription drug channels. Read on for more details. All rights reserved.
98 
Drug Channels
MAY 7, 2024
It's time for Drug Channels ’ annual update of vertical integration among insurers, PBMs, specialty pharmacies, and providers within U.S. drug channels. But until anyone takes action, we will continue to live with the golden rule of the drug channel: Whoever has the gold gets to make the rules. All rights reserved.
Drug Channels
FEBRUARY 27, 2024
In this issue: An update on the retail pharmacy shakeout Arguing for high drug prices A leading researcher provides a 340B reality check Physicians don’t want pharmacists getting uppity Plus, Dave Grohl fights for your right to…have healthcare price transparency? (I Sorry, no Threads.) All rights reserved.
95 
Drug Channels
JANUARY 23, 2024
In a previous article , I highlighted the largest pharmacy chains that will participate in the 2024 Medicare Part D prescription drug plans (PDP). As you will see below, the largest PSAOs have effectively abandoned PDP’s preferred networks in 2024. Look out below! All rights reserved.
70 
Drug Channels
OCTOBER 9, 2024
As regular readers of Drug Channels know, U.S. distribution and dispensing channels for prescription drugs are undergoing significant evolution and consolidation as the changing economics of pharmaceuticals challenge conventional business models. drug wholesaling industry. All rights reserved.
98 
Drug Channels
APRIL 1, 2024
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription. Click here to see the original post from December 2023.
98 
Drug Channels
APRIL 16, 2024
Drug Channels Institute’s (DCI’s) latest analysis finds that participants in the specialty pharmacy market continue to get more diverse—although revenues remain highly concentrated. Read on for DCI’s latest overview of the 2023 marketplace and revenues of the biggest market participants, along with key specialty pharmacy trends.
Drug Channels
AUGUST 6, 2024
In the video excerpt below, I walk through a brief history of 340B contract pharmacies. I conclude with a “follow the dollar” example of 340B prescription economics with contract pharmacies. I conclude with a “follow the dollar” example of 340B prescription economics with contract pharmacies. All rights reserved.
90 
Drug Channels
DECEMBER 5, 2023
Consider two apparently unrelated drug channel anomalies: In McKesson’s 2023 fiscal year, CVS bought $75 billion in pharmaceuticals from McKesson’s wholesale business—a jump of more than 35% compared with the previous year. Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription.
98 
Drug Channels
NOVEMBER 14, 2023
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: Drug Channels Outlook 2024 This event will be broadcast live on Friday, December 15, 2023 12:00 p.m. This event is part of The Drug Channels 2023 Video Webinar Series. Dr. Adam J.
98 
Drug Channels
MARCH 12, 2024
Next week, Drug Channels Institute (DCI) will release our 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. drug pricing, reimbursement, and dispensing system. We’re offering special discounted pricing if you order before April 7, 2024. For 2023, DCI estimates that U.S. to 1:30 p.m.
98 
Drug Channels
MARCH 25, 2024
It’s finally spring in Philadelphia, home of Drug Channels. What’s ahead for the drug channel? Find out during Drug Channel Implications of the Inflation Reduction Act , a new live video webinar with Adam J. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.
Drug Channels
NOVEMBER 28, 2023
In this issue: A reality check on Express Scripts’ purported “cost-based” pharmacy network Mark Cuban explains how and why the PBM market will change Why two drug prices are better than one Pharmacists sing the retail pharmacy shakeout blues Plus, two Philly legends meet at a cardiology conference! d/b/a Drug Channels Institute.
97 
Drug Channels
APRIL 9, 2024
Three is still the magic number for pharmacy benefit managers (PBMs). Read on for Drug Channels Institute’s (DCI’s) latest market share figures, along with a preview of the industry changes that will shift these shares over the next few years. All rights reserved. This Feed is for personal non-commercial use only.
98 
Drug Channels
APRIL 29, 2024
on how Medicare Part D plans will react to the Inflation Reduction Act Walgreens' unexpected specialty pharmacy strength A video deconstruction of my infamous Drug Channels article on GoodRx Plus, a cartoonist illustrates my recent keynote on the battle for oncology margin.
Drug Channels
APRIL 2, 2024
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. For more on acquisition cost reimbursement for pharmacies, see Sections 8.4. of our new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.
75 
Drug Channels
JANUARY 9, 2024
For 2024, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)—have again each excluded 600 or more drugs from their standard formularies. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.
98 
Drug Channels
OCTOBER 2, 2024
This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Click here to see the original post from June 2024. The 340B contract pharmacy market shows little sign of slowing down. Fein, Ph.D.,
52 
Drug Channels
JUNE 12, 2024
The 340B contract pharmacy market shows little sign of slowing down. Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. For an updated look at what’s next for the 340B contract pharmacy market, join Adam J. Fein, Ph.D.,
52 
Drug Channels
JANUARY 30, 2024
But who needs the Super Bowl when you can tackle this month’s selection of notable news stories, intercepted for you from the Drug Channels gridiron: Punt : Average list prices are unchanged for 2024 Trick Play : GSK tussles with PBMs over lower-priced products Rush! Check out the wonderful comments on this LinkedIn post.
75 
Drug Channels
DECEMBER 6, 2023
Is the world ready for new ways to price pharmacy and pharmacy benefit manager (PBM) services? I commend CVS Health for attempting to address key economic challenges facing the retail pharmacy industry and for tackling the hidden complexities of PBM pricing models. d/b/a Drug Channels Institute. Et tu, Walgreens?)
75 
Drug Channels
MARCH 5, 2024
Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s latest live video webinar: Drug Channel Implications of the Inflation Reduction Act This event will be broadcast live on Friday, April 5, 2024, from 12:00 p.m. Pharmacies and Pharmacy Benefit Managers.
98 
Drug Channels
DECEMBER 13, 2024
This week, Im rerunning some popular posts while I prepare for todays Drug Channels Outlook 2025 live video webinar. (If As you will see below, CMS projects that outpatient prescription drugs dispensed by retail and mail pharmacies will remain a small share of total U.S. If you sign up before 12 p.m. spending on healthcare.
98 
Drug Channels
APRIL 8, 2024
I am pleased to announce the inaugural Drug Channels Leadership Forum ! The Leadership Forum will be an executive gathering where drug channel leaders can network and discuss key issues and challenges facing the commercial healthcare system. And of course, I'll be there to moderate the entire event and lead the fireside chats.
97 
Drug Channels
JANUARY 16, 2024
My recent Drug Channels Outlook 2024 webinar covered 12 key trends that will shape the commercial environment this year. The video excerpt below highlights my commentary on trend #2: the rapid growth of anti-obesity GLP-1 agonist drugs. Click here to sign up for The Drug Channels 2024 Video Webinar Series.
98 
Drug Channels
OCTOBER 21, 2024
Informa Connect’s Trade and Channel Strategies December 10-12, 2024 at the W Hotel in Philadelphia, PA Drug Channels readers save 10% with code 24DC10 * Pharmacy and distribution models are growing increasingly complex. Stop running in circles—It’s time to unlock proven strategies to propel market access. Am I still prepared?
FDA Law Blog: Biosimilars
MARCH 24, 2024
By Faraz Siddiqui — As drug manufacturers battle the Health Resources and Services Administration (“HRSA”) in federal courts over the role of 340B contract pharmacies, an Eighth Circuit decision to uphold a 2021 Arkansas law may render those cases inconsequential in that state. Code Ann. § 23-92-604(c)(1), (2) (Act 1103).
59 
Drug Channels
JUNE 18, 2024
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. Click here to see the original post from April 2024. Last week, we documented the substantial concentration of dispensing revenues for specialty drugs.
Drug Channels
APRIL 24, 2024
Last week, we documented the substantial concentration of dispensing revenues for specialty drugs. See The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents. In those exclusive networks, independent and smaller specialty pharmacies are the big winners.
FDA Law Blog: Biosimilars
MAY 30, 2024
Kirschenbaum — Last week, the United States Court of Appeals for the District of Columbia ruled that Section 340B of the Public Health Service Act does not prohibit pharmaceutical manufacturers from imposing conditions on the distribution of discounted drugs to covered entities in the program. In United Therapeutics Corporation v.
59 
Drug Channels
APRIL 4, 2024
This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. For updated data on hospital-owned specialty pharmacies, see Chapter 3 of DCI's new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.
Common Sense for Drug Policy Blog
JUNE 7, 2024
Community Pharmacies and Harm Reduction "Community pharmacies are essential healthcare destinations that serve as an optimal resource for addressing non-urgent inquiries, such as safe injecting practices, management of adverse drug reactions, and medication provision, thus reducing the burden on general practitioners (GPs) [ 1 , 2 ].
Drug Channels
OCTOBER 24, 2023
Open enrollment is under way for the 2024 Medicare Part D plans. Our exclusive analysis of Center for Medicare & Medicaid Services’ (CMS) data reveals that preferred cost sharing pharmacy networks will maintain their dominance as a component of Part D benefit design. The 2024 data provide early evidence of a shrinking PDP market.
52
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content